(Q39728481)

14 September 2017

Recursive partitioning for risk stratification in men undergoing repeat prostate biopsies (English)

1 reference

14 September 2017

Mark Garzotto

1

1 reference

14 September 2017

Yon Park

2

1 reference

14 September 2017

Solange Mongoue-Tchokote

3

1 reference

14 September 2017

Jesse Bledsoe

4

1 reference

14 September 2017

Laura Peters

5

1 reference

14 September 2017

Bruce H Blank

6

1 reference

14 September 2017

Donald Austin

7

1 reference

14 September 2017

Tomasz M Beer

8

1 reference

14 September 2017

Motomi Mori

9

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

14 September 2017

1 reference

14 September 2017

104

1 reference

14 September 2017

9

1 reference

14 September 2017

1911-1917

1 reference

Prostate biopsy: how many cores are enough?

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

Enthusiasm for cancer screening in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Analysis of repeated biopsy results within 1 year after a noncancer diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

A neurocomputational model for prostate carcinoma detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Predictors of prostate cancer after initial negative systematic 12 core biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21420

7 January 2021

Identifiers

DOI

10.1002/CNCR.21420

1 reference

14 September 2017

1 reference